Skip to main content

Cardiac Syncope

  • Chapter
  • First Online:
Book cover Syncope

Abstract

“Cardiac syncope” comprises those causes of syncope that are primarily due to disturbances of cardiac or cardiovascular function.1 Thus, cardiac conduction system disease, primary cardiac rhythm disturbances, and cardiovascular structural abnormalities are incorporated within this category (previously “cardiac arrhythmias” and “structural cardiac and cardiovascular disease” were considered as separate classes2,3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moya A, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–2671.

    Article  PubMed  Google Scholar 

  2. Brignole M, et al. Guidelines on management (diagnosis and treatment) of syncope. Europace. 2004;6:467–537.

    Article  PubMed  Google Scholar 

  3. Jhanjee R, et al. Syncope. Mosby: Disease-a-Month; 2009:527–586.

    Google Scholar 

  4. Soteriades ES, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885.

    Article  PubMed  Google Scholar 

  5. Savage DD, et al. Epidemiologic features of isolated syncope: The Framingham Study. Stroke. 1985;16:626–629.

    Article  PubMed  CAS  Google Scholar 

  6. Pires LA, et al. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators. Am J Cardiol. 2000;85:725–728.

    Article  PubMed  CAS  Google Scholar 

  7. Olshansky B, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J. 1999;137:878–886.

    Article  PubMed  CAS  Google Scholar 

  8. Steinberg JS, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics versus implantable defibrillators. J Cardiovasc Electrophysiol. 2001;12:996–1001.

    Article  PubMed  CAS  Google Scholar 

  9. Knight BP, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol. 1999;33: 1964–1970.

    Article  PubMed  CAS  Google Scholar 

  10. Olshansky B, et al. Syncope predicts the outcome of cardiomyopathy patients: Analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008;51:1277–1282.

    Article  PubMed  Google Scholar 

  11. Sauer A, et al. Long QT Syndrome in Adults. J Am Coll Cardiol. 2007;49:329–337.

    Article  PubMed  Google Scholar 

  12. Sacher F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A Multicenter Study. Circulation. 2006;114:2317–2324.

    Article  PubMed  Google Scholar 

  13. Sarkozy A, et al. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334–344.

    Article  PubMed  Google Scholar 

  14. Paparella G, et al. Brugada syndrome: The prognostic dilemma and value of syncope. Minerva Med. 2009;100:307–319.

    PubMed  CAS  Google Scholar 

  15. Paul M, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: A meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126–2133.

    Article  PubMed  Google Scholar 

  16. Alboni P, et al. The diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37:1921–1928.

    Article  PubMed  CAS  Google Scholar 

  17. Del Rosso A, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005;96:1431–1435.

    Article  PubMed  Google Scholar 

  18. Del Rosso A, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008;94:1620–1626.

    Article  PubMed  Google Scholar 

  19. Colivicchi F, et al. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J. 2004;25:1749–1753.

    Article  PubMed  Google Scholar 

  20. Benditt DG, et al. Sinus node dysfunction. In: Willerson JT, Cohn JN, eds. Cardiovascular Medicine. 3rd edn. Edinburgh: Churchill Livingstone; 2006:1925–1935.

    Google Scholar 

  21. Benditt DG, et al. Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation. 1987;75(Suppl III):93–99.

    Google Scholar 

  22. Raj S. Highlights in clinical autonomic neurosciences. Orthostatic tachycardia and orthostatic hypotension. Autonom Neurosci Basic and Clin. 2010;154:1–2.

    Google Scholar 

  23. Gann D, et al. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979;90:24–29.

    PubMed  CAS  Google Scholar 

  24. Fragakis N, et al. The value of adenosine test in the diagnosis of sick sinus syndrome: susceptibility of sinus and atrioventricular node to adenosine in patients with sick sinus syndrome and unexplained syncope. Europace. 2007;9:559–562.

    Article  PubMed  Google Scholar 

  25. Flammang D, et al. The adenosine triphosphate (ATP) test for evaluation of syncope of unknown origin. J Cardiovasc Electrophysiol. 2005;16:1388–1389.

    Article  PubMed  Google Scholar 

  26. Perennes A, et al. Epidemiology, clinical features, and follow-up of patients with syncope and a positive adenosine triphosphate test result. J Am Coll Cardiol. 2006;47:594–597.

    Article  PubMed  Google Scholar 

  27. Brignole M, et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J. 2006;27:2232–2239.

    Article  PubMed  Google Scholar 

  28. Menozzi C, et al. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation. 2002;105:2741–2745.

    Article  PubMed  Google Scholar 

  29. Brignole M, et al. Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001;104:2045–2050.

    Article  PubMed  CAS  Google Scholar 

  30. Brignole M, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Task Force members. Europace. 2009;11:671–687.

    Article  PubMed  Google Scholar 

  31. Brignole M, et al. Improved arrhythmia detection in implantable loop recorders. J Cardiovasc Electrophysiol. 2008;19:928–934.

    Article  PubMed  Google Scholar 

  32. Villain E. Indications for pacing in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008;31(Suppl 1):S17–S20.

    Article  PubMed  Google Scholar 

  33. Michaelsson M, et al. A natural history of congenital atrio-ventricular block. Pacing Clin Electrophysiol. 1997;20:2098–2101.

    Article  PubMed  CAS  Google Scholar 

  34. Camm AJ, Lau CP. Syncope of undetermined origin: diagnosis and management. Prog Cardiol. 1988;1:139–156.

    Google Scholar 

  35. Maron BJ, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113:1807–1816.

    Article  PubMed  Google Scholar 

  36. Corrado D, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091.

    Article  PubMed  Google Scholar 

  37. Maron BJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–2816.

    Article  PubMed  Google Scholar 

  38. Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009;6:984–992.

    Article  PubMed  Google Scholar 

  39. Farzaneh-Far A, Lerman BB. Idiopathic ventricular outflow tract tachycardia. Heart. 2005;91:136–138.

    Article  PubMed  CAS  Google Scholar 

  40. Chun KR, et al. Left ventricular outflow tract tachycardia including ventricular tachycardia from the aortic cusps and epicardial ventricular tachycardia. Herz. 2007;32:226–232.

    Article  PubMed  Google Scholar 

  41. Jackman WM, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988;31:115–172.

    Article  PubMed  CAS  Google Scholar 

  42. Moss AJ, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–1144.

    Article  PubMed  CAS  Google Scholar 

  43. Schwartz PJ, et al. Stress and sudden death: the case of the long QT syndrome. Circulation. 1991;83(Suppl II):71–80.

    Google Scholar 

  44. Moss AJ, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929–2934.

    Article  PubMed  CAS  Google Scholar 

  45. Zareba W, Cygankiewicz I. Long QT syndrome and short QT syndrome. Prog Cardiovasc Dis. 2008;51:264–278.

    Article  PubMed  Google Scholar 

  46. Johnson JN, Ackerman MJ. QTc: How long is too long? Br J Sports Med. 2009;43:657–662.

    Article  PubMed  CAS  Google Scholar 

  47. Colman N, et al. Value of history-taking in syncope patients: In whom to suspect long QT syndrome?. Europace. 2009;11:937–943.

    Article  PubMed  Google Scholar 

  48. Antzelevitch C, et al. Brugada syndrome: report of the second consensus conference. Circulation. 2005;111:659–670.

    Article  PubMed  Google Scholar 

  49. Spirito P, et al. Implantable cardioverter defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Am Med Assoc. 2007;298:405–412.

    Article  Google Scholar 

  50. Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703–1710.

    Article  PubMed  Google Scholar 

  51. Nallamothu BK, et al. Syncope in acute aortic dissection: Diagnostic, prognostic and clinical implications. Am J Med. 2002;113:468–471.

    Article  PubMed  Google Scholar 

  52. Krahn AD, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104:46–51.

    Article  PubMed  CAS  Google Scholar 

  53. Krahn AD, et al. Cost implications of testing strategy in patients with syncope. Randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42:495–501.

    Article  PubMed  Google Scholar 

  54. Brignole M, et al. Early application of an implantable loop recorder allows a mechanism-based effective therapy in patients with recurrent suspected neurally-mediated syncope. Eur Heart J. 2006;27:1085–1092.

    Article  PubMed  Google Scholar 

  55. Morady F, et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol. 1983;2:1053–1059.

    Article  PubMed  CAS  Google Scholar 

  56. Sra JS, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 1991;114:1013–1019.

    PubMed  CAS  Google Scholar 

  57. Fujimura O, et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by bradycardia. N Engl J Med. 1989;321:1703–1707.

    Article  PubMed  CAS  Google Scholar 

  58. Brembilla-Perrot B, et al. Are the results of electrophysiological study different in patients with a pre-excitation syndrome, with and without syncope? Europace. 2008;10:175–180.

    Article  PubMed  Google Scholar 

  59. Brembilla-Perrot B, et al. Increased sensitivity of electrophysiological study by isoproterenol infusion in unexplained syncope. Int J Cardiol. 2006;106:82–87.

    Article  PubMed  Google Scholar 

  60. Chen LY, et al. Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope. J Interv Card Electrophysiol. 2005 Nov;14:99–105.

    Article  PubMed  Google Scholar 

  61. Brilakis ES, et al. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: A case series and a systematic review of the literature. Int J Cardiol. 2005;98:395–401.

    Article  PubMed  Google Scholar 

  62. Fitzpatrick A, et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J. 1991;12:389–394.

    PubMed  CAS  Google Scholar 

  63. McDermott D, et al. Acute myocardial infarction in patients with syncope. Can J Emerg Med. 2009;11:156–160.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michele Brignole .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Brignole, M., Benditt, D.G. (2011). Cardiac Syncope. In: Syncope. Springer, London. https://doi.org/10.1007/978-0-85729-201-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-201-8_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-200-1

  • Online ISBN: 978-0-85729-201-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics